跳至主要内容
临床试验/NL-OMON55759
NL-OMON55759已完成不适用

Optimal early recognition of persons at high risk of aneurysmal subarachnoid haemorrhage - ERASE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age between 20 and 70 years
  • - At least one first degree relative with an unruptured intracranial aneurysm
  • identified by MRA, CTA or conventional angiography

排除标准

  • - People who do not speak Dutch well enough to give informed consent
  • - Any first degree relative with an aneurysmal subarachnoid hemorrhage
  • - A history of an aneurysmal subarachnoid hemorrhage and/or unruptured
  • intracranial aneurysm
  • - A history of polycystic kidney disease, Ehlers-Danlos, or fibromuscular
  • - Relative contraindication(s) for MRA, e.g. pregnancy, an internal metal
  • device such as a pacemaker, or claustrophobia
  • - A serious condition that would interfere with the treatment of an UIA, e.g.
  • severe comorbidity or reduced life expectancy

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验